comparemela.com

Latest Breaking News On - Richardj cote - Page 1 : comparemela.com

AI may predict spread of lung cancer to brain

AI may predict spread of lung cancer to brain
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Richardj-cote
Ramaswamy-govindan
Changhuei-yang
Margaret-gladys-smith
Mark-watson
Washington-university-school-of-medicine
Washington-university
Anheuser-busch
Siteman-cancer-center
California-institute-of-technology
Department-of-pathology-immunology
Washington-university-school

AI Technique Could Offer Tailored Cancer Treatments

When treating patients with early-stage lung cancer, physicians must decide whether to proceed with potentially beneficial but toxic therapies like chemotherapy, radiation, or immunotherapy to remove cancer and reduce the likelihood that it will spread to the brain, or whether to wait and see if lung surgery alone is adequate.

United-states
Richardj-cote
Margaret-gladys-smith
Ramaswamy-govindan
Changhuei-yang
Mark-watson
Department-of-pathology-immunology
Washington-university
California-institute-of-technology
Louis-school-of-medicine-personalized-initiative
Washington-university-school-of-medicine
Anheuser-busch

AI may predict spread of lung cancer to brain - The Source - Washington University in St. Louis

A new study led by Washington University School of Medicine in St. Louis could help physicians strike the right balance when treating lung cancer patients. Scientists used an artificial intelligence (AI) method to study lung biopsy images and predict whether the cancer will spread to the brain.

Changhuei-yang
Margaret-gladys-smith
Mark-watson
Richardj-cote
Ramaswamy-govindan
Department-of-pathology-immunology
Anheuser-busch
California-institute-of-technology
Siteman-cancer-center
Washington-university-school-of-medicine
Washington-university
Washington-university-school

Medicare approves genetic test for solid tumors - The Source - Washington University in St. Louis

GatewaySeq, a genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis, has been approved for reimbursement by the Centers for Medicare & Medicaid Services.

Richardj-cote
Lulu-sun
David-spencer
Eric-duncavage
Mcdonnell-genome-institute
Department-of-pathology-immunology
Washington-university
School-of-medicine
Matt-miller-school-of-medicine
Genome-institute
Via-washington-university-pathology-services
Centers-for-medicare-medicaid-services

vimarsana © 2020. All Rights Reserved.